16 9月 2022 by admin in UncategorizedComments Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
15 9月 2022 by admin in UncategorizedComments Syros and Tyme Technologies Announce Stockholder Approval of Merger
15 8月 2022 by admin in UncategorizedComments Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates
08 8月 2022 by admin in UncategorizedComments Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
04 8月 2022 by admin in UncategorizedComments NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results
04 8月 2022 by admin in UncategorizedComments Laronde Appoints John Mendlein as Chief Executive Officer
03 8月 2022 by admin in UncategorizedComments Syros Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Tamibarotene for the Treatment of MDS
